Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Kizilbash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2011 - 2014
- Emory UniversityMPH, Health Outcomes, 2008 - 2011
- Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 2005 - 2008
- Aga Khan Medical CollegeClass of 2003
Certifications & Licensure
- MN State Medical License 2011 - 2026
- FL State Medical License 2016 - 2019
- MI State Medical License 2005 - 2012
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Start of enrollment: 2011 Oct 01
- Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Start of enrollment: 2016 Jul 01
- Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma Start of enrollment: 2019 May 01
- Join now to see all
Publications & Presentations
PubMed
- Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas.Mohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, Rebecca Salvatori, Alan R Penheiter
Clinical Cancer Research. 2025-05-01 - Antitumor activity of vebreltinib and characterization of clinicogenomic features in solid tumors with MET rearrangements.Seshiru Nakazawa, Federica Pecci, Igor Odintsov, Dimitris Gazgalis, Felix H Gottlieb
Cancer Discovery. 2025-04-10 - Veliparib Plus Temozolomide for MGMT-Methylated Glioblastoma-Reply.Jann N Sarkaria, Sani H Kizilbash, Caterina Giannini
JAMA Oncology. 2025-03-13
Press Mentions
- Beating Back a Brain Tumor Amid LossJune 17th, 2019
Grant Support
- Phase I study to evaluate safety, tolerability, pharmacokinetics and anti-tumor activity of WSD0922-FUMAYO CLINIC ROCHESTER2021–2025
- Phase I study to evaluate safety, tolerability, pharmacokinetics and anti-tumor activity of WSD0922-FUMAYO CLINIC ROCHESTER2021–2025
Professional Memberships
- Member
- Member
- Society of NeuroncologyMember
Other Languages
- Urdu
External Links
- Mayo Clinichttp://www.mayoclinic.org/biographies/kizilbash-sani-h-mbbs-m-p-h/bio-20116924
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
